2presents OHC loss (A) and IHC loss (B) in tub/tub mice like a function of cochlear size (cochleogram). 2), a transcription element that regulates manifestation of Trx and TrxR while others, was also suppressed in the tubby mouse cochlea. Furthermore, a lowered level of triggered extracellular signal-regulated kinase (p-ERK) was observed in the tubby mouse cochlea. In contrast, caspase-3 manifestation and activity Cyclosporin H were enhanced in the tubby mouse, suggesting apoptotic cell death. The tub-related molecular alterations in the cochlea were prevented by chronic treatment with SF. As a result, the SF-treatment significantly delayed the tub-related cochlear degeneration. Other unknown proteins may contribute to tubby-related degeneration because Nrf2 regulates many other antioxidants besides Trx/TrxR and sulforaphane did not prevent cochlear degeneration completely although it completely prevented alterations of Nrf2 and Trx/TrxR. Keywords:Tubby mice, Age-related hearing loss, Thioredoxin, Extracellular Cyclosporin H signal-regulated kinase, Caspase, Sulforaphane == 1. Intro == The tubby strain of obese mice arose spontaneously inside a mouse colony in the Jackson Laboratory (Coleman and Eicher, 1990). It is an autosomal recessive mutation, mapping to mouse chromosome 7 (North et al., 1997). The mutation has been associated with Cyclosporin H a G Rabbit Polyclonal to p70 S6 Kinase beta (phospho-Ser423) T transversion, which abolishes a donor splice site in the gene and results in a larger transcript comprising the unspliced intron (Noben-Trauth et al., 1996). The tubby phenotype is definitely characterized by late-onset weight gain accompanied by progressive cochlear and retinal degeneration (Ohlemiller et al., 1995,1997). The combination of these phenotypes resembles human being syndromes, such as Ushers (retinal and cochlear degeneration), Bardet-Biedl, and Alstroms (obesity and sensory deficits). The tubby is definitely a loss-of-function mutation of the tub gene and that loss of the tub gene is sufficient to give rise to the full spectrum of tubby phenotypes (Stubdal et al., 2000). A progressive hearing loss was reported in the tubby mouse after 3 weeks of age (Heckenlively et al., 1995;Ikeda et al., 1999). A slightly delayed cochlear degeneration was also reported (Ohlemiller et al., 1995,1997). The mutation caused outer hair cell (OHC) loss in the intense basal region (hook area) by one month of age and the damaged area expanded to the apical change by about 6 months of age. The inner hair cells (IHCs) were affected in the hook region by about 6 months of age (Ohlemiller et al., 1995,1997). Yet, the mechanism underlying the death of auditory hair cells in the tubby mouse is still unclear. Reduction/oxidation (redox) imbalance is Cyclosporin H related to many kinds of diseases (Fujino et al., 2006). Thioredoxin (Trx) and Trx reductase (TrxR), with NADPH, compose an important redox system in the cell (Buchanan et al., 1994;Fujino et al., 2006;Holmgren, 1995). Trx is definitely characterized by a redox active site with the sequence of -Trp-Cys-Gly-Pro-Cys-Lys-. The two cysteine residues within the redox active center provide the sulfhydryl organizations involved in reducing activity. The Trx can be oxidized by free radicals, such as reactive oxygen varieties (ROS). The oxidized form Trx (Trx-S2), comprising a disulfide bridge in the active site, is reduced to a dithiol (Trx-(SH)2) by TrxR in the presence of NADPH. Besides Cyclosporin H functioning as an antioxidant, Trx has also been identified as an interacting partner or a physiological inhibitor of ASK1 (apoptosis signal-regulating kinase 1), which is a mitogen-activated protein kinase kinase kinase (MAP3K), and activation of which initiates cellular stress response signaling cascades including JNK and p38 pathways (Ichijo et al., 1997;Roberts and Der, 2007). The reduced form of Trx binds to and inhibits ASK1 and the subsequent activation of JNK/p38 activities and apoptotic processes (Saitoh et al., 1998). In contrast, oxidization of Trx by ROS releases Trx from ASK1 leading to JNK and p38 activities and then caspase activation and apoptotic cell.